New cholesterol guidelines: Worth the wait?

被引：26
作者：
Raymond, Chad [1 ]
Cho, Leslie [1 ]
Rocco, Michael [1 ,2 ]
Hazen, Stanley L. [1 ,2 ]
机构：
[1] Cleveland Clin, Inst Heart & Vasc, Sect Prevent Cardiol, Cleveland, OH 44195 USA
[2] Case Western Reserve Univ, Lerner Coll Med, Cleveland Clin, Cleveland, OH 44106 USA
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2014年 / 81卷 / 01期
关键词：
CORONARY-HEART-DISEASE; PRIMARY PREVENTION; CARDIOVASCULAR-DISEASE; MYOCARDIAL-INFARCTION; ATORVASTATIN; EVENTS; SIMVASTATIN; PRAVASTATIN; AVERAGE; MEN;
D O I：
10.3949/ccjm.81a.13161
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：11 / 19
页数：9
相关论文
共 39 条
  • [31] A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women
    Ridker, PM
    Cook, NR
    Lee, IM
    Gordon, D
    Gaziano, JM
    Manson, JE
    Hennekens, CH
    Buring, JE
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2005, 352 (13) : 1293 - 1304
  • [32] The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels
    Sacks, FM
    Pfeffer, MA
    Moye, LA
    Rouleau, JL
    Rutherford, JD
    Cole, TG
    Brown, L
    Warnica, JW
    Arnold, JMO
    Wun, CC
    Davis, BR
    Braunwald, E
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1996, 335 (14) : 1001 - 1009
  • [33] Effects of atorvastatin on early recurrent ischemic events in acute coronary syndromes - The MIRACL study: A randomized controlled trial
    Schwartz, GG
    Olsson, AG
    Ezekowitz, MD
    Ganz, P
    Oliver, MF
    Waters, D
    Zeiher, A
    Chaitman, BR
    Leslie, S
    Stern, T
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2001, 285 (13): : 1711 - 1718
  • [34] Prevention of coronary and stroke events with atorvastatin in hypertensive patients who have average or lower-than-average cholesterol concentrations, in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm (ASCOT-LLA):: a multicentre randomised controlled trial
    Sever, PS
    Dahlöf, B
    Poulter, NR
    Wedel, H
    Beevers, G
    Caulfield, M
    Collins, R
    Kjeldsen, SE
    Kristinsson, A
    McInnes, GT
    Mehlsen, J
    Nieminen, M
    O'Brien, E
    Östergren, J
    [J]. LANCET, 2003, 361 (9364) : 1149 - 1158
  • [35] PREVENTION OF CORONARY HEART-DISEASE WITH PRAVASTATIN IN MEN WITH HYPERCHOLESTEROLEMIA
    SHEPHERD, J
    COBBE, SM
    FORD, I
    ISLES, CG
    LORIMER, AR
    MACFARLANE, PW
    MCKILLOP, JH
    PACKARD, CJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1995, 333 (20) : 1301 - 1307
  • [36] 2013 ACC/AHA Guideline on the Treatment of Blood Cholesterol to Reduce Atherosclerotic Cardiovascular Risk in Adults A Report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines
    Stone, Neil J.
    Robinson, Jennifer G.
    Lichtenstein, Alice H.
    Merz, C. Noel Bairey
    Blum, Conrad B.
    Eckel, Robert H.
    Goldberg, Anne C.
    Gordon, David
    Levy, Daniel
    Lloyd-Jones, Donald M.
    McBride, Patrick
    Schwartz, J. Sanford
    Shero, Susan T.
    Smith, Sidney C., Jr.
    Watson, Karol
    Wilson, Peter W. F.
    [J]. CIRCULATION, 2014, 129 (25) : S1 - S45
  • [37] The PDAY study: Natural history, risk factors, and pathobiology
    Strong, JP
    Malcom, GT
    Oalmann, MC
    Wissler, RW
    [J]. ATHEROSCLEROSIS IV: RECENT ADVANCES IN ATHEROSCLEROSIS RESEARCH: THE FOURTH SARATOGA INTERNATIONAL CONFERENCE ON ATHEROSCLEROSIS, 1997, 811 : 226 - 237
  • [38] Tonkin A, 1998, NEW ENGL J MED, V339, P1349
  • [39] THE ATHEROSCLEROSIS RISK IN COMMUNITIES (ARIC) STUDY - DESIGN AND OBJECTIVES
    WILLIAMS, OD
    [J]. AMERICAN JOURNAL OF EPIDEMIOLOGY, 1989, 129 (04) : 687 - 702
1234